Sara McGeorge

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy

Chathur Acharya, Sara McGeorge, Andrew Fagan, James B. Wade, Hannah Lee, Velimir Luketic, Richard K. Sterling, Leroy Thacker, Jasmohan S. Bajaj – 16 July 2022 – Driving is independently affected by cirrhosis and hepatic encephalopathy (HE) and alcohol/substance use, but their concomitant impact is unclear. We aimed to determine the impact of alcohol and other substances on driving‐simulator performance in cirrhosis with and without HE.

Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis

Somaya Albhaisi, Amirhossein Shamsaddini, Andrew Fagan, Sara McGeorge, Masoumeh Sikaroodi, Edith Gavis, Samarth Patel, Brian C. Davis, Chathur Acharya, Richard K. Sterling, Scott Matherly, Michael Fuchs, Patrick M. Gillevet, Jasmohan S. Bajaj – 24 January 2021 – The gut microbiome is altered in cirrhosis. Recent evidence has suggested a key role for the gut microbiota in the progression of cirrhosis and the development of hepatocellular carcinoma (HCC).

Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID‐19: A Multicenter Cohort

Jasmohan S. Bajaj, Guadalupe Garcia‐Tsao, Florence Wong, Scott W. Biggins, Patrick S. Kamath, Sara McGeorge, Michael Chew, Meredith Pearson, Jawaid Shaw, Anita Kalluri, Andrew Fagan, Amy Olofson, Maryam Moini, Randolph Rosa Rodriguez, K. Rajender Reddy – 10 January 2021